Biggest News Aggregation in the World
📰 Medication Guide News

Page 20 - Medication Guide News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Medication Guide. Real-time updates on events, politics, business and more.

Moderna, Inc.: Moderna and Merck Announce mRNA-4157 in Combination With KEYTRUDA Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following

MRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of distant metastasis or death by 65% (HR=0.347 [95% CI, 0.145-0.828]); one-sided p value=0.0063) compared to KEYTRUDA aloneThe DMFS results
United States United Kingdom Kyle Holen Peter Dannenbaum Colleen Hussey Julie Cunningham

LUPKYNIS® (voclosporin) Achieved Significantly Higher Renal Response in Lupus Nephritis Patients with High Proteinuria Compared to Patients Treated with MMF and Low Dose Steroids Alone

Aurinia Pharmaceuticals Inc. today announced the results of a post-hoc, pooled analysis of the Phase 2 AURA-LV and Phase 3 AURORA 1 studies, which found that LUPKYNIS® with mycophenolate... | June 1, 2023
United States Emily Littlejohn Greg Keenan Aurinia Pharmaceuticals European Congress Aurinia Pharmaceuticals Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Axsome Therapeutics to Present Data and Post-Hoc Analyses on Auvelity® and Sunosi® at the 2023 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

Data on Auvelity demonstrating improved functioning in major depressive disorder Data on Sunosi demonstrating improved cognitive function in patients with excessive daytime sleepiness associated with... | May 30, 2023
United States New York Gregory Mattingly Rakesh Jain Eileen Leary Andrew Cutler

Johnson & Johnson : Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Investigational Single Tablet Combination Therapy of Macitentan and Tadalafil for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)

RARITAN, NJ,May 30, 2023 - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a New Drug Application to the U.S. Food and Drug Administration ... | May 30, 2023
Shelly Orlacchio Tina Kitt World Health Organization Group Janssen Research Development Companies Of Johnson European Society Of Cardiology Respiratory

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science